Tradestie Institutional Equity Comparison Engine

PRTO vs TENX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TENX Overall Edge

TENX Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenax Therapeutics, Inc. (TENX) driven by superior Valuation, Growth & Margin while PRTO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PRTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus TENX at 0.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TENX sits in BREAKDOWN (24th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TENX
PRTO N/M vs TENX 0.3x Fwd P/E
Growth & Margin Winner TENX
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner PRTO
1Y -3.4% vs -82.9% ยท 52W Pos 0% vs 0%
Options & Structure Winner PRTO
UNCLASSIFIED (N/A IV) vs BREAKDOWN (24th %ile IV)
PRTO US Equity
PRTO
Institutional Equity
$24.45
-3.36% 1D
Market Cap N/A
1M Return -9.56%
1Y Return -3.39%
Forward P/E N/M
Unified AI Score
33.3 / 100 SELL
Tech 12.0 Fund 36.0 Flow 50.0 Mom 34.0
TENX NASDAQ
Tenax Therapeutics, Inc.
Pharmaceutical Preparations
$1.25
-10.07% 1D
Market Cap $63.3M
1M Return -28.98%
1Y Return -82.92%
Forward P/E 0.3x
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 57.0 Flow 66.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PRTO -3.39% TENX -82.92% Spread: +87.68 pp (PRTO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PRTO TTM Op. Margin: N/A TENX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRTO vs TENX. Trailing 12-month operating profitability (PRTO N/A vs TENX 0.0%) and valuation multiples (PRTO N/M vs TENX 0.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PRTO (1) vs TENX (8)
Institutional Metric PRTO TENX Criterion Row Winner
Market Capitalization Scale N/A $63.3M Larger Scale TENX
Trailing P/E Ratio Valuation N/M 0.3x Lower Multiple TENX
Forward P/E Ratio Valuation N/M 0.3x Lower Multiple TENX
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth TENX
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin TENX
Net Profit Margin Profitability N/A 0.0% Higher Margin TENX
Return on Equity (ROE) Capital Efficiency N/A -64.2% Higher ROE TENX
52-Week Range Position Momentum 0% ($24โ€“$29) 0% ($1โ€“$19) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 21% Vol 1.42ฮฒ ยท 75% Vol Lower Realized Risk PRTO
Unified Institutional Score Composite Signal 33.3 / 100 (SELL) 45.5 / 100 (HOLD) Higher Composite TENX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PRTO vs TENX Buy Guide
PRTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PRTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TENX BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 24th %ile
IV Regime Compressed (<25th %ile)
Live TENX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PRTO nor TENX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.